- stock
- bulk
Supplier Type
- Trader
- contract manufacturer
- custom synthesis
- Manufacturer
- Reagent
Supplier Region
- Maharashtra(34)
- New Delhi(7)
- Hyderabad(43)
- Pune(8)
- Gujarat(36)
- Beijing(3)
- Mumbai(75)
- Karnataka(6)
- Andhra Pradesh(5)
- Delhi(11)
- Ahmedabad(11)
- Tamil Nadu(2)
- Haryana(3)
- Vadodara(10)
- Punjab(1)
- Bangalore(2)
- Telangana(3)
- Uttar Pradesh(2)
- Madhya Pradesh(3)
- Kerela(1)
- Ujjain(1)
- Kolkata(1)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Purity By Gc Nlt 98%
- NLT95%
- NLT 95%
- NLT 90.00%
- NLT 90%
- N/A
- more than 95%
- more than 90%
- min 99%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- good
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.99
- 99.98%
- 99.95%
- 99.91%
- 99.90%
- 99.9%
- >99.9%
- 99.9 %
- 99.86%
- 99.85%
- 99.80 %
- 99.73%
- 99.6
- 99.5%+
- 99.5%
- 99.5 %
- 99.42%
- 99.29%
- 99%+
- 99% Minimum
- 99% Min
- 99% ABOVE
- >99%
- 99%
- 99 %
- 99
- 98+
- 98.60%
- 98.12%
- 98.0 %
- 98% min
- >98%
- 98%
- 98 %
- 97-99%
- 97-99 %
- 97.57%
- >97%
- 97%
- 97 to 98
- 97 %
- 96.80%
- 96.39%
- 96% - 98%
- 96%
- 95-99%
- 95-98%
- >95%
- 95%
- 95
- >92%
- >90%
- 90%
- 65%
- 600
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25MG
- 100Mg
- 1g
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1000g
- 1kg
- ml
- 5kg
- 10kg
- 25kg
- 5020050 Kg Drum / 200 Kg Drum
- 37kg
- gms
- 50kg
- 5>
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 77kg
- 85kg
- 500kg
- 1000kg
- 95NLT %
- 200Kg drum
- 500>
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 100kg
- 200kg
- 250kg
- 1MT
- 20ISO tank of MT
-
Almotriptan malate
181183-52-8
-
MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
149457-03-4
-
3''-Acetyl-2''-hydroxy-4-(4-phenylbutoxy)benzanilide
136450-06-1
-
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-
162012-67-1
-
N-Acetyl-L-cysteine
616-91-1
-
([1-Phenyl-meth-(E)-ylidene]-amino)-acetic acid ethyl ester
40682-54-0
-
LDAO
1643-20-5
-
N,N-Dimethylformamide
68-12-2
-
(IR,2S)-I-N,N-Diethylnorephedrine HCL
37025-59-5
-
N-Hydroxyphthalimide
524-38-9
Almotriptan malate 181183-52-8
N-(3-Chloro-4-fluoro-phenyl)-7-fluoro-6-nitro-quinazolin-4-amine 162012-67-1
N-Acetyl-L-cysteine 616-91-1
Ethyl N-benzylideneglycinate 40682-54-0
N,N-Dimethylformamide 68-12-2
(1R,2S)-I-N,N-Diethylnorephedrine Hydrochloride 37025-59-5
N-Hydroxyphthalimide 524-38-9
N-Bromosuccinimide 128-08-5
N-(2-Hydroxypropyl)Methacrylamide 21442-01-3
N-Cetyl-N,N,N-trimethylammonium chloride 112-02-7

